Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Cardiovascular Drugs and Therapy|February 12, 2022
Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and MechanismsTetsuji Miura, Tatsuya Sato, Toshiyuki Yano, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 21, 2018
Does p53 Inhibition Suppress Myocardial Ischemia-Reperfusion Injury?Toshiyuki Yano, Koki Abe, Masaya Tanno, et al.
Cardiovascular Research|March 17, 2004
The role of ADAM protease in the tyrosine kinase-mediated trigger mechanism of ischemic preconditioningYoshihiko Ichikawa, Tetsuji Miura, Atsushi Nakano, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 14, 2002
Opening of mitochondrial K(ATP) channel occurs downstream of PKC-epsilon activation in the mechanism of preconditioningYoshito Ohnuma, Tetsuji Miura, Takayuki Miki, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 22, 2007
Delta-opioid receptor activation before ischemia reduces gap junction permeability in ischemic myocardium by PKC-epsilon-mediated phosphorylation of connexin 43Tetsuji Miura, Toshiyuki Yano, Kazuyuki Naitoh, et al.
Journal of Diabetes Investigation|May 16, 2019
Longitudinal impact of dapagliflozin treatment on ventricular repolarization heterogeneity in patients with type 2 diabetesTatsuya Sato, Takayuki Miki, Shinya Furukawa, et al.
Cardiovascular Research|February 14, 2004
Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotectionYasuhiro Nishino, Tetsuji Miura, Takayuki Miki, et al.
Basic Research in Cardiology|September 1, 2006
Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathwayTakayuki Miki, Tetsuji Miura, Masaya Tanno, et al.
Pageof 10